Supporting Information Subjects and Methods

Exome Sequencing
In Families A and B, about 213,000 exonic regions from the genomic DNA of two family members (Fig 1A, IV-1 and III-10; Fig 1B, II-7 and III-6) were captured and enriched using the Agilent SureSelect Human All Exon 50 Mb kit according to the manufacturer's protocol (Agilent, CA). The DNA sequencing libraries were prepared using Illumina's paired end DNA sample preparation kit according to the manufacturer's instruction. The enriched samples were sequenced on the Illumina HiSeq2000 (Illumina, CA) platform using paired-end 2x100 bp protocol. All sequenced reads were mapped to the human reference genome (GRCh37 patch 2, obtained from ftp://ftp.ensembl.org/pub/release-61/) using the Burrows-Wheeler Aligner (BWA). 1 PCR duplicates were removed from the alignments using SAMtools, and then the variant calling was performed using SAMtools/BCFTools (http://samtools.sourceforge.net/mpileup.shtml). 2 To further ensure that the collected variants were of high confidence, we preserved only the variants with Phred-like confidence scores at least 30.0, as was suggested by GATK (http://www.broadinstitute.org/gsa/wiki/index.php/Best_Practice_Variant_Detection_ with_the_GATK_v3) for processing high-coverage (>10x) datasets.
In Family C, exome capture was performed on the two most distantly related affected individuals (IV-6 and IV-7, see Fig 1 C ) of the pedigree and was followed by next generation sequencing using an Illumina Hiseq2000 Instrument. Sequence reads were aligned to the human hg19 genome using bwa 1 and duplicated reads were removed using samtools. 
In silico analyses
The residue changes identified were further evaluated by in silico analyses with the following programs: SIFT, PMut and Polyphen 2. 
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Results
Exome Sequencing Identifies KCND3 Mutations in Families with Dominant Ataxia
In Family A, 53.9 and 50.9 million sequencing reads were produced for the two samples, comprising 5.39 and 5.09 billion bases, respectively. About 93% and 93.7%
of the reads for both samples, respectively, could be aligned to the human reference genome. About 0.4% of the targeted exon regions in IV-1 and about 1% of these regions in III-10 were un-sequenced. The average sequencing depths for the targeted exonic regions were approximately 105x and 96x, respectively, for these two samples.
After analysis and filtering (Supplementary Table 1A) , 489 heterozygous coding variants were shared by both patients and were not present in the dbSNP, the 1000
Genomes Project or the exome data from 10 non-SCA ethnic controls. Among these variants, 11 were located in the 1p21-q23 region, to which SCA19/22 is linked.
Sanger sequencing of these variants in other 23 family members, including 11 patients, 6 unaffected individuals and 6 married-in spouses, identified only one variant, c.679_681delTTC in KCND3 gene, completely segregating with the disease phenotype. (Fig 2A) This mutation putatively results in a deletion of phenylalanine at position 227 (p.F227del) of Kv4.3. The deleted phenylalanine of Kv4.3 is highly conserved across a wide variety of species, from zebrafish, frog, platypus and mouse to humans. (Fig 2E) This mutation was not found in 500 normal Chinese controls.
Mutations were also not found in KCND3 in 105 unrelated probands with dominant ataxia or 55 patients with sporadic cerebellar ataxia in Taiwan by sequence analysis.
In Family B, whole genome scan analysis identified 11 regions cosegregating with the disease with LOD scores from -1 to +2.8. Variants not in dbSNP or 1000 genomes database 8,102
Variants not found in other 10 non-SCA patients' exome data 5,715
Variants resulting in amino acid sequence changes 489
Variants present in the linked region (1p21-q23) 11
Variants completely segregating with disease phenotype in the pedigree 1
III-6 II-7
Variants 43364 39777
Variants present in the affected but absent in the unaffected father 1648
Heterozygous variants 1240
Variants resulting in amino acid sequence changes 146
Variants not in dbSNP or 1000 genomes database 13
Variants present in the 11 linked regions 5
Variants absent in Exome variant server and local 31 exomes 3
Variants segregating with disease phenotype in the pedigree 3 (including one on chromosome 1)
Supplementary Table 3. Bioinformatic analysis of exome sequencing in Family C
IV-6
IV-7
Variants 23475 28549
Variants present in both affected individuals as heterozygotes 5514
Variants present in at least one individual that fall in the 11 potentially linked regions
1769
Variants resulting in amino acid sequence or splice site changes and absent in dbSNP and 1000 genomes
31
Variants also present in the two shared large haplotypes 13
Variants (of these) predicted to be damaging, not present in the exome server, and segregating with the family 
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